Nexien BioPharma, Inc.
NXEN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.08K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7,077.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -0.88 |
| Outstanding Shares | 70,772,196 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Nexien BioPharma, Inc.
10 employees
CEO: Richard S. Greenberg
Nexien BioPharma, Inc., a pharmaceutical firm headquartered in Glendale, Colorado, concentrates its efforts on the research, advancement, and market introduction of cannabinoid-derived medications. The company utilizes both pre-clinical ...